IGF2BP3 promotes the stability and translation of epidermal growth factor receptor (EGFR) mRNA and further activates the EGFR pathway by cooperating with METTL14 to increase cetuximab resistance in CRC cells (Chen L. J. et al., 2023). The gene discussed is EGFR; the disease is colorectal carcinoma.